Skip to content
AwardedPOLGoods

Zakup i dostawa produktu leczniczego Lisocabtagene maraleucel w ramach programu lekowego B.12.FM

Published
Published 29 April 2026

Overview

1. Przedmiotem zamówienia jest dostawa produktu leczniczego Lisocabtagene maraleucel w ramach programu lekowego B.12.FM 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 1 do Zaproszenia do negocjacji.

Key details

Country
POL
Status
Awarded
Category
Goods
Procedure
Direct
Published
29 April 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
PLN 16,828,000
Award date
21 April 2026
Contract period
— → 16 April 2027
Winners
  • BRISTOL MYERS SQUIBB POLSKA Sp. z o.o. - członek konsorcjum
  • URTICA Sp. z o.o. - lider konsorcjum

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    16 June 2026

  2. Contract Notice

    29 April 2026

Contracting authority

  • Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego

    Procuring entity

    Warszawa, POL

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Zakup i dostawa produktu leczniczego Lisocabtagene maraleucel w ramach programu lekowego B.12.FM — won by BRISTOL MYERS SQUIBB POLSKA Sp. z o.o. - członek konsorcjum +1 — Skim